Home About us Editorial board Ahead of print Current issue Archives Submit article Instructions Subscribe Search Contacts Login 
  • Users Online: 123
  • Home
  • Print this page
  • Email this page
REVIEW ARTICLE
Year : 2012  |  Volume : 24  |  Issue : 4  |  Page : 330-333

Bisphosphonates and osteonecrosis of jaws


1 Professor, Department of Periodontics, Vydehi Institute of Dental Sciences and Research Center, Bengaluru, Karnataka, India
2 Professor, Department of Oral Medicine and Radiology, Seema Dental College and Hospital Rishikesh, Uttarakhand, India

Correspondence Address:
Vijay Raghavan
Professor, Department of Oral Medicine and Radiology, Seema Dental College and Hospital Rishikesh, Uttarakhand
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.5005/jp-journals-10011-1323

Rights and Permissions

Bisphosphonates are used to treat osteoporosis. Paget disease of bone and other metabolic bone diseases, multiple myeloma, and skeletal events associated with metastatic neoplasms- In 2003, the first reports describing osteonecrosis of the jaw (ONJ) in patients receiving bisphosphonates were published. About 95% of these cases occurred among cancer patients receiving high-dose intravenous bisphosphonates. Approximately 5% of the reported cases have been in osteoporosis patients receiving low dose bisphosphonate therapy. The mandible is more commonly affected than the maxilla (2:1 ratio), and 60% of cases are preceded by a dental surgical procedure. Oversuppression of bone turnover is probably the primary mechanism for the development of this condition, although there may be contributing comorbid factors. All sites of potential jaw infection should be eliminated before bisphosphonates therapy is initiated in these patients to reduce the necessity of subsequent dentoalveolar surgery. Conservative debridement of necrotic bone, pain control, infection management, use of antimicrobial oral rinses, and withdrawal of bisphosphonates are preferable to aggressive surgical measures for treating this condition. The purpose of the present article is to enlighten the dental fraternity about this frequently prescribed class of drugs with regard to its types and mode of action, and the implication of bisphosphonates-induced ONJ.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed170    
    Printed1    
    Emailed0    
    PDF Downloaded74    
    Comments [Add]    

Recommend this journal